DAPAGLIFLOZIN, Placebo for dapagliflozin film-coated tablets 10 mg
202100617
Phase 3 small_molecule active
Quick answer
DAPAGLIFLOZIN, Placebo for dapagliflozin film-coated tablets 10 mg for Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active